Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Cardiac Science Corporation (“Cardiac Science” or the “Company”) (NASDAQ: CSCX) for potential breaches of fiduciary duties in connection with their conduct related to the sale of the Company to Opto Circuits Limited. The proposed transaction offers Cardiac Science shareholders to only receive $2.30 per share in cash. The transaction is structured as a tender offer which may obviate the need for a shareholder vote. According to Thomson/First Call, at least one financial analyst values Cardiac Science’ common stock at $6.00 per share.

Request more information now by clicking here: www.faruqilaw.com/cscx

Whether the Cardiac Science’s Board of Directors breached their fiduciary duties to Cardiac Science’s stockholders by failing to conduct an adequate and fair sales process to sell the Company prior to agreeing to this proposed transaction, whether the proposed transaction undervalues Cardiac Science’s shares and by how much this proposed transaction undervalues the Company to the detriment of Cardiac Science shareholders are the key focus of this investigation.

Faruqi & Faruqi, LLP is a national law firm which represents investors and individuals in class action litigation. The firm is focused on providing exemplary legal services in complex litigation in the areas of securities, shareholder, antitrust and consumer litigation, through all phases of litigation. The firm has an experienced trial team which has achieved significant victories on behalf of the firm’s clients.

If you own common stock in Cardiac Science and wish to obtain additional information, please visit us at www.faruqilaw.com/cscx or contact Juan E. Monteverde, Esq. either via e-mail at jmonteverde@faruqilaw.com or by telephone at (877) 247-4292 or (212) 983-9330.

Attorney Advertising. (C) 2010 Faruqi & Faruqi, LLP. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We are happy to discuss your particular case.

Cardiac Science Corp (MM) (NASDAQ:CSCX)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Cardiac Science Corp (MM) Charts.
Cardiac Science Corp (MM) (NASDAQ:CSCX)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Cardiac Science Corp (MM) Charts.